Innovating Works

Antaros

Desconocido
Immune-Image: Immune Image Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies ANTAROS MEDICAL AB participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage Immunotherapies have emerged as effective treatments for immune system-related diseases, such as cancer and inflammatory diseases. Although...
2019-09-26 - 2026-03-31 | Financiado
LITMUS: Liver Investigation Testing Marker Utility in Steatohepatitis ANTAROS MEDICAL AB participó en un H2020: H2020-JTI-IMI2-2016-09-two-stage Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, Non-Alcoholic Fatty Liv...
2017-10-09 - 2024-02-29 | Financiado
IB4SD-TRISTAN: Imaging Biomarkers IBs for Safer Drugs Validation of Translational Imaging Methods in Drug Safety... ANTAROS MEDICAL AB participó en un H2020: H2020-JTI-IMI2-2015-07-two-stage 1.Our consortium has broad, deep experience of drug development and imaging biomarker (IB) validation. We are internationally recognized exp...
2017-03-10 - 2024-12-31 | Financiado
BEAt-DKD: Biomarker Enterprise to Attack DKD Sofia ref. 115974 ANTAROS MEDICAL AB participó en un H2020: H2020-JTI-IMI2-2015-05-two-stage Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD), and its global incidence and prevalence have reached e...
2016-12-20 - 2023-08-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.